511509 Stock Overview
Provides drug development and discovery services to pharmaceutical and biotech companies worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Vivo Bio Tech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹38.93 |
| 52 Week High | ₹56.00 |
| 52 Week Low | ₹31.20 |
| Beta | 0.84 |
| 1 Month Change | -2.63% |
| 3 Month Change | -0.69% |
| 1 Year Change | 17.15% |
| 3 Year Change | -38.21% |
| 5 Year Change | 44.72% |
| Change since IPO | -45.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 511509 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 4.3% | -2.1% | -2.1% |
| 1Y | 17.2% | 52.4% | 22.5% |
Return vs Industry: 511509 underperformed the Indian Life Sciences industry which returned 52.4% over the past year.
Return vs Market: 511509 underperformed the Indian Market which returned 22.5% over the past year.
Price Volatility
| 511509 volatility | |
|---|---|
| 511509 Average Weekly Movement | 5.9% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 511509 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 511509's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 161 | Alangudi Sankaranarayanan | www.vivobio.com |
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets.
Vivo Bio Tech Limited Fundamentals Summary
| 511509 fundamental statistics | |
|---|---|
| Market cap | ₹539.95m |
| Earnings (TTM) | ₹74.57m |
| Revenue (TTM) | ₹467.77m |
7.8x
P/E Ratio1.2x
P/S RatioIs 511509 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 511509 income statement (TTM) | |
|---|---|
| Revenue | ₹467.77m |
| Cost of Revenue | ₹54.50m |
| Gross Profit | ₹413.26m |
| Other Expenses | ₹338.69m |
| Earnings | ₹74.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.00 |
| Gross Margin | 88.35% |
| Net Profit Margin | 15.94% |
| Debt/Equity Ratio | 96.8% |
How did 511509 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 15:06 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vivo Bio Tech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|